Metropolitan Life Insurance Company (MetLife)’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,847
| Closed | -$127K | – | 265 |
|
|
2024
Q1 | $127K | Sell |
3,847
-370
| -9% | -$12.2K | 0.01% | 924 |
|
|
2023
Q4 | $115K | Hold |
4,217
| – | – | 0.01% | 1005 |
|
|
2023
Q3 | $101K | Buy |
4,217
+483
| +13% | +$11.6K | 0.01% | 1004 |
|
|
2023
Q2 | $119K | Buy |
3,734
+208
| +6% | +$6.64K | 0.01% | 928 |
|
|
2023
Q1 | $108K | Sell |
3,526
-402
| -10% | -$12.3K | 0.01% | 962 |
|
|
2022
Q4 | $154K | Buy |
3,928
+92
| +2% | +$3.6K | 0.01% | 834 |
|
|
2022
Q3 | $183K | Hold |
3,836
| – | – | 0.01% | 707 |
|
|
2022
Q2 | $148K | Buy |
3,836
+572
| +18% | +$22.1K | 0.01% | 851 |
|
|
2022
Q1 | $187K | Sell |
3,264
-9,829
| -75% | -$563K | 0.01% | 848 |
|
|
2021
Q4 | $1.04M | Hold |
13,093
| – | – | 0.01% | 930 |
|
|
2021
Q3 | $1.14M | Buy |
13,093
+228
| +2% | +$19.8K | 0.02% | 855 |
|
|
2021
Q2 | $1.66M | Buy |
12,865
+2,028
| +19% | +$261K | 0.02% | 640 |
|
|
2021
Q1 | $867K | Sell |
10,837
-422
| -4% | -$33.8K | 0.01% | 1058 |
|
|
2020
Q4 | $919K | Buy |
11,259
+705
| +7% | +$57.6K | 0.01% | 936 |
|
|
2020
Q3 | $260K | Buy |
10,554
+5,872
| +125% | +$145K | ﹤0.01% | 1618 |
|
|
2020
Q2 | $131K | Hold |
4,682
| – | – | ﹤0.01% | 2092 |
|
|
2020
Q1 | $84.3K | Buy |
+4,682
| New | +$84.3K | ﹤0.01% | 2136 |
|